MedImmune LLC
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 1987-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://medimmune.com
Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-524 in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2009-01-29
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 30
- Registration Number
- NCT00192465
- Locations
- ๐บ๐ธ
SFBC International, Inc, Miami, Florida, United States
Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk
- Conditions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2007-05-07
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 1500
- Registration Number
- NCT00192439
- Locations
- ๐จ๐ฆ
University of Alberta, Edmonton, Alberta, Canada
๐บ๐ธLebonheur Children's Medical Center, Memphis, Tennessee, United States
๐บ๐ธChildren's Memorial Hospital, Chicago, Illinois, United States
Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis
- Conditions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-10-25
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 120
- Registration Number
- NCT00192452
- Locations
- ๐บ๐ธ
MDS Pharma Services (US) Inc., Phoenix, Arizona, United States
๐บ๐ธNorthwest Kinetics, Tacoma, Washington, United States
๐บ๐ธWake Forest University School of Medicine, Winston-Salem, North Carolina, United States
Trial of the Safety, Transmissibility, and Phenotypic and Genotypic Stability of Influenza Virus Vaccine,(CAIV-T), in Children Who Attend Day Care. (Final Report Version 2.0)
- Conditions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-10-25
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 200
- Registration Number
- NCT00192361
- Locations
- ๐ซ๐ฎ
Kauppakatu Clinic, Tampere, Finland
Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.
- Conditions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-10-03
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 2160
- Registration Number
- NCT00192400
Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma
- Conditions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-10-03
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 2229
- Registration Number
- NCT00192257
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children
- Conditions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-10-03
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 3000
- Registration Number
- NCT00192244
- Locations
- ๐จ๐ณ
The Prince of Wales Hospital, Hong Kong, China
Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children
- Conditions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2006-10-03
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 2200
- Registration Number
- NCT00192205
- Locations
- ๐ช๐ธ
Hospital de Txagorritxu, Vitoria, Spain
๐ฎ๐ฑSchneider Children's Medical Center of Israel, Petah-Tikva, Israel
Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza
- Conditions
- Interventions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2012-03-14
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 3009
- Registration Number
- NCT00192413
- Locations
- ๐ฟ๐ฆ
Jansen van Rensburg, Amanzimtoti, South Africa
๐ฟ๐ฆDocnor House, Durban North, Dwazulu Natal, South Africa
๐ฟ๐ฆHazelmed Family Practice, Hazelwood, Pretoria, South Africa
Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2012-03-06
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 498
- Registration Number
- NCT00192270
- Locations
- ๐ง๐ช
University of Antwerp, Antwerp, Belgium
๐ง๐ชDienst Jeugdgezondheidszorg, Leuven, Belgium
๐ซ๐ฎOulu University Hospital, Oulu, Finland